{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3605, 
        3611
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3792, 
        3798
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3612, 
        3621
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3799, 
        3808
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3085, 
        3108
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9135, 
        9155
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3234, 
        3261
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3284, 
        3289
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3420, 
        3425
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3538, 
        3543
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9033, 
        9038
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9067, 
        9072
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9101, 
        9106
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3266, 
        3279
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3309, 
        3319
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3402, 
        3415
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3445, 
        3455
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9046, 
        9060
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9080, 
        9094
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        761, 
        790
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8467, 
        8502
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9002, 
        9028
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3321, 
        3350
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3457, 
        3486
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3596, 
        3604
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3809, 
        3816
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3629, 
        3630
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3824, 
        3825
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3544, 
        3550
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9039, 
        9045
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9073, 
        9079
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9107, 
        9113
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3552, 
        3559
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3263, 
        3265
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3399, 
        3401
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3535, 
        3537
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9030, 
        9032
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9064, 
        9066
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9098, 
        9100
      ]
    }
  ], 
  "Supplementary Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8143, 
        8175
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8177, 
        8192
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4168, 
        4185
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1084007^CLIA|eMARCPlus|TN Cancer Registry|20170913130734||ORU^R01^ORU_R01|201709131307340001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-ES-011361^PathSys^44D1084007^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170817000000|||||||20170818000000|&Sentinel Lymph Node, Sentinel Lymph Node, Breast, Mastectomy - partial/simple, PQRS Breast Cancer Resection|1861486797^^^^^^MD^^CMS^D^^^NPI||||||20170821000000|||F||||||C50.911^Malignant neoplasm of unspecified site of right female breast^I10~D05.11^Intraductal carcinoma in situ of right breast^I10~N60.81^Other benign mammary dysplasias of right breast^I10~Z17.0^Estrogen receptor positive status [ER+]^I10|1083668453&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe patient is \"\", identified by requisition and container labels. 1. Specimen 1 is labeled \"sentinel nodes-rt. breast, #1-7229\" on both the requisition and the container. Received in formalin is a candidate lymph node, 0.9 x 0.6 x 0.5 cm, with adherent fatty tissue. The specimen is bisected and totally submitted in cassette 1A. 2. Specimen 2 is labeled \"sentinel nodes-rt. breast, #2-1960\" on both the requisition and the container. Received in formalin is a piece of fatty tissue, 3.8 x 2.4 x up to 0.7 cm. Sectioning and palpation reveals 1 candidate lymph node, 1.4 x 0.8 x 0.6 cm, which is bisected and totally submitted in cassette 2A. 3. Specimen 3 is labeled \"rt. breast partial mastectomy, single suture-superior, double suture-lateral\" on the requisition, \"rt. breast mastectomy, single suture- superior, double suture-lateral\" on the container. Received in formalin is a 182 g piece of fatty tissue without skin, 10.5 cm from medial to lateral, 8.2 cm from superior to inferior, up to 3.9 cm from anterior to posterior. Orienting sutures are present as indicated on the requisition and container. The anterior margin is marked with surgical ink. A wire marker has been inserted from the anterior surface of the specimen. An additional wire marker has been inserted from the posterior surface of the specimen. Prior to sectioning, the anterior margin is inked yellow, the posterior margin black, the superior margin blue, the inferior margin green, the medial margin and the lateral margin orange and the medial margin red. Sectioning reveals an area of firm white tissue, 1.8 x 1.5 x 1.2 cm, grossly consistent with tumor and biopsy site. A metal clip is present in this area. This area grossly approaches to within 0.5 cm of the posterior margin, to within 1.1 cm of the anterior margin and to within 1.2 cm of the superior margin. The lesion is greater than 2 cm from all remaining margins. Sectioning through the remainder of the specimen reveals fatty and fibrofatty tissue. additional lesions are not grossly identified. Representative sections are processed. Section summary:   3A-C, lesion, sections include superior and posterior margins   3D, lesion, section includes superior margin   3E, anterior margin   3F, inferior margin   3G, medial margin   3H, lateral margin\n\n\nPath report.relevant Hx\n\nHistory - Malignant neoplasm of central portion of right female breast (C50.111) - right breast invasive ductal carcinoma\n\n\nPath report.final diagnosis\n\n1. Sentinel node #1, right, excision:     One lymph node, negative for metastatic tumor by H and E and keratin       immunostain (0/1). 2. Sentinel node #2, right, excision:     One lymph node, negative for metastatic tumor by H and E and keratin       immunostain (0/1). 3. Right breast, central, partial mastectomy/lumpectomy:     Invasive ductal carcinoma, grade 2 of 3, measuring 2.3 x 1.7 cm in greatest       microscopic dimensions and associated with prior biopsy site.     Negative for angiolymphatic invasion.     Focal ductal carcinoma in situ, grade 2 of 3 (not extensive).     Invasive carcinoma focally contacts posterior margin; DCIS is 3 mm from this       (closest) margin.     Background breast tissue demonstrate fibrocystic changes, focal atypical       lobular hyperplasia, and microcalcifications associated with DCIS and non-       neoplastic epithelium.     Stage: pT2, N0(i-)(sn). CANCER CHECKLIST: INVASIVE CARCINOMA OF THE BREAST 3.000.001.1000043 CLINICAL  Clinical History: Other (specify)  Other (specify): Prior malignant core biopsy: 17-70-1166 SPECIMEN  Procedure: Excision (less than total mastectomy)  Specimen Laterality: Right TUMOR  Tumor Site: Invasive Carcinoma: Central  Specify Clock Position of Tumor Site: 12 o'clock, per prior core bx  Histologic Type: Invasive carcinoma of no special type (ductal, not otherwise specified)  Glandular (Acinar) / Tubular Differentiation: Score 3 (< 10% of tumor area forming glandular / tubular structures)  Nuclear Pleomorphism: Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)  Mitotic Rate: Score 1 (<=3 mitoses per mm2)  Overall Grade: Grade 2 (scores of 6 or 7)  Tumor Size: Greatest dimension of largest invasive focus > 1 mm (specify exact measurement in Millimeters (mm)):  Greatest dimension of largest invasive focus > 1 mm (specify exact measurement in Millimeters (mm)):: Microscopically: 23 x 17mm  Tumor Focality: Single focus of invasive carcinoma  Ductal Carcinoma In Situ (DCIS): DCIS is present in specimen, Negative for extensive intraductal component (EIC)  Size (Extent) of DCIS: Estimated size (extent) of DCIS (greatest dimension using gross and microscopic evaluation) in Millimeters (mm) is at least  Estimated size (extent) of DCIS (greatest dimension using and microscopic evaluation) in Millimeters (mm) is at least: A few small aggregates, largest measuring 2mm  Number of Blocks with DCIS: 1  Number of Blocks Examined: 8  Architectural Patterns: Cribriform, Solid, focally spindled  Nuclear Grade (see Table 2 in CAP Protocol): Grade II (intermediate)  Necrosis: Present, focal (small foci or single cell necrosis) Tumor Extent  Skin: Skin is not present  Skeletal Muscle: No skeletal muscle is present Accessory Findings  Lymphovascular Invasion: Not identified  Microcalcifications: Present in DCIS, Present in non-neoplastic tissue MARGINS  Distance from Anterior Margin in Millimeters (mm): 9mm  Distance from Posterior Margin in Millimeters (mm): POSITIVE  Distance from Superior Margin in Millimeters (mm): 3mm  Distance from Inferior Margin in Millimeters (mm): Greater than 10mm  Distance from Medial Margin in Millimeters (mm): Greater than 10mm  Distance from Lateral Margin in Millimeters (mm): Greater than 10mm  Invasive Carcinoma Margins: Positive for invasive carcinoma  Specify Margin(s): Posterior  Extent of Posterior Margin Involvement: Multifocal (focally contacting, multifocally within microns)  DCIS Margins: Uninvolved by DCIS (DCIS present in specimen)  Distance of DCIS to Anterior Margin in Millimeters (mm): Greater than 10mm  Distance of DCIS to Posterior Margin in Millimeters (mm): 3mm  Distance of DCIS to Superior Margin in Millimeters (mm): Greater than 10mm  Distance of DCIS to Inferior Margin in Millimeters (mm): Greater than 10mm  Distance of DCIS to Medial Margin in Millimeters (mm): Greater than 10mm  Distance of DCIS to Lateral Margin in Millimeters (mm): Greater than 10mm LYMPH NODES  Number of Lymph Nodes with Macrometastases (> 2 mm): Specify number  Specify number: 0  Number of Lymph Nodes with Micrometastases (> 0.2 mm to 2 mm and / or > 200 cells): Specify number  Specify number: 0  Number of Lymph Nodes with Isolated Tumor Cells (<= 0.2 mm and <= 200 cells)#: Specify number  Specify number: 0  Number of Lymph Nodes Examined: Specify number  Specify number: 2  Number of Sentinel Nodes Examined: Specify number  Specify number: 2 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition)  Primary Tumor (Invasive Carcinoma) (pT): pT2: Tumor > 20 mm but <= 50 mm in greatest dimension Regional Lymph Nodes (pN)  Modifier: (sn): Only sentinel node(s) evaluated. If 6 or more nodes (sentinel or nonsentinel) are removed, this modifier should not be used.  Category (pN): pN0: No regional lymph node metastasis identified or ITCs only#\n\n\nPath report.supplemental reports\n\nAddendum Report: A block was sent to Agendia for MammaPrint 70-Gene Breast Cancer Recurrence Assay and the results are as follows:  Summary of Results: Low Risk, +0.147  A full report is on the file in the pathology department, and is available on request.  ## End of auxiliary report ##\n\n\nPath report.microscopic examination\n\nFindings not reported elsewhere: Fibrocystic changes are present (apocrine metaplasia/cysts, fibrosis, usual ductal hyperplasia, sclerosing adenosis) as well as focal columnar cell changes. Please see cancer staging summary below for additional details regarding neoplasm. Occasional foci are seen morphologically suggestive of possible angiolymphatic invasion. CD31 stain was applied (blocks 3A, B) with satsifactory positive and negative controls, and fails to confirm angiolymphatic invasion.\n\n\nPath report.site of origin\n\n1. Right breast sentinel nodes #1 2. Right breast sentinel nodes #2 3. Right breast partial mastectomy\n\n\nPath report.comments\n\nComments - Prognostic markers performed on prior core biopsy (17-70-1166, right breast, 12- o'clock central, core biopsy): ER/PR positive, Ki-67 25%, HER-2 negative (1+). Please see that report for additional details.\n\n\n"
}